This common vitamin could help fight one of the deadliest brain cancers

In a small trial, high-dose vitamin B3 (niacin) added to standard glioblastoma treatment showed early promise, with 82% of patients remaining progression-free after six months. Researchers believe niacin may help revive immune cells suppressed by the cancer, but larger studies are still needed to confirm the benefit and safety.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.